Precision medicine: from science to value

GS Ginsburg, KA Phillips - Health affairs, 2018 - healthaffairs.org
Precision medicine is making an impact on patients, health care delivery systems, and
research participants in ways that were only imagined fifteen years ago when the human …

[HTML][HTML] Personalized medicine and the power of electronic health records

NS Abul-Husn, EE Kenny - Cell, 2019 - cell.com
Personalized medicine has largely been enabled by the integration of genomic and other
data with electronic health records (EHRs) in the United States and elsewhere. Increased …

[HTML][HTML] GA4GH: International policies and standards for data sharing across genomic research and healthcare

HL Rehm, AJH Page, L Smith, JB Adams, G Alterovitz… - Cell genomics, 2021 - cell.com
Summary The Global Alliance for Genomics and Health (GA4GH) aims to accelerate
biomedical advances by enabling the responsible sharing of clinical and genomic data …

Artificial intelligence and personalized medicine

NJ Schork - Precision medicine in Cancer therapy, 2019 - Springer
The development of high-throughput, data-intensive biomedical research assays and
technologies has created a need for researchers to develop strategies for analyzing …

Exome sequencing–based screening for BRCA1/2 expected pathogenic variants among adult biobank participants

K Manickam, AH Buchanan, MLB Schwartz… - JAMA Network …, 2018 - jamanetwork.com
Importance Detection of disease-associated variants in theBRCA1andBRCA2 (BRCA1/2)
genes allows for cancer prevention and early diagnosis in high-risk individuals. Objectives …

[HTML][HTML] Clinical outcomes of a genomic screening program for actionable genetic conditions

AH Buchanan, HL Kirchner, MLB Schwartz, MA Kelly… - Genetics in …, 2020 - Elsevier
Purpose Three genetic conditions—hereditary breast and ovarian cancer syndrome, Lynch
syndrome, and familial hypercholesterolemia—have tier 1 evidence for interventions that …

[HTML][HTML] A model for genome-first care: returning secondary genomic findings to participants and their healthcare providers in a large research cohort

MLB Schwartz, CZ McCormick, AL Lazzeri… - The American Journal of …, 2018 - cell.com
There is growing interest in communicating clinically relevant DNA sequence findings to
research participants who join projects with a primary research goal other than the clinical …

[HTML][HTML] Quantifying the polygenic contribution to variable expressivity in eleven rare genetic disorders

MT Oetjens, MA Kelly, AC Sturm, CL Martin… - Nature …, 2019 - nature.com
Rare genetic disorders (RGDs) often exhibit significant clinical variability among affected
individuals, a disease characteristic termed variable expressivity. Recently, the aggregate …

Opportunities, resources, and techniques for implementing genomics in clinical care

TA Manolio, R Rowley, MS Williams, D Roden… - The Lancet, 2019 - thelancet.com
Advances in technologies for assessing genomic variation and an increasing understanding
of the effects of genomic variants on health and disease are driving the transition of …

Testing and management of iron overload after genetic screening–identified hemochromatosis

JM Savatt, A Johns, MLB Schwartz… - JAMA Network …, 2023 - jamanetwork.com
Importance HFEgene–associated hereditary hemochromatosis type 1 (HH1) is
underdiagnosed, resulting in missed opportunities for preventing morbidity and mortality …